Patents by Inventor Leonard Liebes

Leonard Liebes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9018259
    Abstract: The present invention provides a method of treating cancer using benzoic acid derivatives, alone or in combination with standard treatments such as chemotherapy and radiotherapy. Also provided are methods of screening for benzoic derivatives based on their ability to inhibit the enzyme tyrosinase or to bind to and activate PXR/SXR xenobiotic receptors.
    Type: Grant
    Filed: May 14, 2012
    Date of Patent: April 28, 2015
    Assignee: New York University
    Inventors: Peter C. Brooks, Danielle Morais, Leonard Liebes, Dorothy Rodriguez
  • Patent number: 8710099
    Abstract: The present invention provides a method of treating cancer using the sodium salt of a benzoic acid derivative, alone or in combination with standard treatments such as chemotherapy and radiotherapy.
    Type: Grant
    Filed: September 10, 2010
    Date of Patent: April 29, 2014
    Assignees: New York University, Maine Medical Center
    Inventors: Peter C. Brooks, James Canary, Leonard Liebes
  • Publication number: 20120329861
    Abstract: The present invention provides a method of treating cancer using benzoic acid derivatives, alone or in combination with standard treatments such as chemotherapy and radiotherapy. Also provided are methods of screening for benzoic derivatives based on their ability to inhibit the enzyme tyrosinase or to bind to and activate PXR/SXR xenobiotic receptors.
    Type: Application
    Filed: May 14, 2012
    Publication date: December 27, 2012
    Applicant: NEW YORK UNIVERSITY
    Inventors: Peter C. Brooks, Danielle Morais, Leonard Liebes, Dorothy Rodriguez
  • Publication number: 20120203051
    Abstract: The present invention provides a method of treating cancer using the sodium salt of a benzoic acid derivative, alone or in combination with standard treatments such as chemotherapy and radiotherapy.
    Type: Application
    Filed: September 10, 2010
    Publication date: August 9, 2012
    Applicants: MAINE MEDICAL CENTER, NEW YORK UNIVERSITY
    Inventors: Peter C. Brooks, James Canary, Leonard Liebes
  • Patent number: 8198328
    Abstract: The present invention provides a method of treating cancer using benzoic acid derivatives, alone or in combination with standard treatments such as chemotherapy and radiotherapy. Also provided are methods of screening for benzoic derivatives based on their ability to inhibit the enzyme tyrosinase or to bind to and activate PXR/SXR xenobiotic receptors.
    Type: Grant
    Filed: January 19, 2005
    Date of Patent: June 12, 2012
    Assignee: New York University
    Inventors: Peter C. Brooks, Danielle Morais, Leonard Liebes, Dorothy Rodriguez
  • Patent number: 7705049
    Abstract: The present invention relates to a method for treating non-melanotic cancers by administration of PABA. The present invention also relates to the potentiation of standard cancer treatment of radiation, radioimmunotherapy, and/or chemotherapy using PABA.
    Type: Grant
    Filed: January 20, 2005
    Date of Patent: April 27, 2010
    Assignee: New York University
    Inventors: Peter C. Brooks, Leonard Liebes, Elissa Kramer, Bruce Ng, Danielle Morais
  • Publication number: 20050220705
    Abstract: The present invention relates to a method for treating non-melanotic cancers by administration of PABA. The present invention also relates to the potentiation of standard cancer treatment of radiation, radioimmunotherapy, and/or chemotherapy using PABA.
    Type: Application
    Filed: January 20, 2005
    Publication date: October 6, 2005
    Applicant: New York University
    Inventors: Peter Brooks, Leonard Liebes, Elissa Kramer, Bruce Ng
  • Publication number: 20050209334
    Abstract: The present invention provides a method of treating cancer using benzoic acid derivatives, alone or in combination with standard treatments such as chemotherapy and radiotherapy. Also provided are methods of screening for benzoic derivatives based on their ability to inhibit the enzyme tyrosinase or to bind to and activate PXR/SXR xenobiotic receptors.
    Type: Application
    Filed: January 19, 2005
    Publication date: September 22, 2005
    Applicant: New York University
    Inventors: Peter Brooks, Danielle Morais, Leonard Liebes, Dorothy Rodriguez